0001192482-19-000274.txt : 20190604
0001192482-19-000274.hdr.sgml : 20190604
20190604161741
ACCESSION NUMBER: 0001192482-19-000274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190531
FILED AS OF DATE: 20190604
DATE AS OF CHANGE: 20190604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ciaffoni Joseph
CENTRAL INDEX KEY: 0001443841
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 19876812
MAIL ADDRESS:
STREET 1: C/O ENDO HEALTH SOLUTIONS INC.
STREET 2: 1400 ATWATER DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-05-31
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001443841
Ciaffoni Joseph
C/O COLLEGIUM PHARMACEUTICAL, INC.
100 TECHNOLOGY CENTER DRIVE
STOUGHTON
MA
02072
1
1
0
0
President and CEO
Common Stock
2019-05-31
4
S
0
5851
11.52
D
190755
D
Common Stock
2019-05-31
4
F
0
3097
11.51
D
187658
D
Common Stock
2019-06-03
4
S
0
7436
11.59
D
180222
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.44 to $11.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4).
Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.45 to $11.72, inclusive
/s/ Paul Brannelly as Attorney-In-Fact For Joseph Ciaffoni
2019-06-04